Low Levels of Antiretroviral‐Resistant HIV Infection in a Routine Clinic in Cameroon that Uses the World Health Organization (WHO) Public Health Approach to Monitor Antiretroviral Treatment and Adequacy with the WHO Recommendation for Second‐Line
about
Viral suppression after 12 months of antiretroviral therapy in low- and middle-income countries: a systematic reviewEarly warning indicators for HIV drug resistance in Cameroon during the year 2010Population-based monitoring of emerging HIV-1 drug resistance on antiretroviral therapy and associated factors in a sentinel site in Cameroon: low levels of resistance but poor programmatic performanceMonitoring HIV Drug Resistance Early Warning Indicators in Cameroon: A Study Following the Revised World Health Organization RecommendationsLow Incidence of HIV-1C Acquired Drug Resistance 10 Years after Roll-Out of Antiretroviral Therapy in Ethiopia: A Prospective Cohort StudyDeclining trends in early warning indicators for HIV drug resistance in Cameroon from 2008-2010: lessons and challenges for low-resource settings.Virological success after 12 and 24 months of antiretroviral therapy in sub-Saharan Africa: Comparing results of trials, cohorts and cross-sectional studies using a systematic review and meta-analysis.Monitoring of antiretroviral therapy and mortality in HIV programmes in Malawi, South Africa and Zambia: mathematical modelling studyLong-Term Outcome of an HIV-Treatment Programme in Rural Africa: Viral Suppression despite Early MortalityRates of emergence of HIV drug resistance in resource-limited settings: a systematic review.High prevalence of HIV-1 drug resistance among patients on first-line antiretroviral treatment in Lomé, Togo.Strategies for monitoring and evaluation of resource-limited national antiretroviral therapy programs: the two-phase design.The HIV-1 epidemic: low- to middle-income countries.Prevalence of HIV drug resistance before and 1 year after treatment initiation in 4 sites in the Malawi antiretroviral treatment programA retrospective survey of HIV drug resistance among patients 1 year after initiation of antiretroviral therapy at 4 clinics in MalawiHIV-1 genetic diversity and drug resistance among Senegalese patients in the public health system.Virological outcome and patterns of HIV-1 drug resistance in patients with 36 months' antiretroviral therapy experience in CameroonImpact of HIV drug resistance on virologic and immunologic failure and mortality in a cohort of patients on antiretroviral therapy in China.Cost-effectiveness of point-of-care viral load monitoring of antiretroviral therapy in resource-limited settings: mathematical modelling study.Increasing rate of TAMs and etravirine resistance in HIV-1-infected adults between 12 and 24 months of treatment: the VOLTART cohort study in Côte d'Ivoire, West Africa.Virologic Failure and Human Immunodeficiency Virus Drug Resistance in Rural Cameroon With Regard to the UNAIDS 90-90-90 Treatment Targets.Viral Suppression and HIV Drug Resistance at 6 Months Among Women in Malawi's Option B+ Program: Results From the PURE Malawi Study.[Representations of therapeutic failure of ARV treatment among patients and health care professionals in Dakar].High level of HIV-1 resistance in patients failing long-term first-line antiretroviral therapy in Mali.Drug resistance mutations and genetic diversity in adults treated for HIV type 1 infection in Mauritania.Performance evaluation of an in-house human immunodeficiency virus type-1 protease-reverse transcriptase genotyping assay in Cameroon.Characterization of drug resistance mutations in naïve and ART-treated patients infected with HIV-1 in Yaounde, Cameroon.[HIV/AIDS treatment in Africa: free to limit costs].
P2860
Q26823588-93D6CB25-5C39-41D9-8DA8-3441CCBFD917Q28483799-0036243E-680A-42E3-B0C8-961BF4318128Q28535652-FC66C5A0-B5E3-4AEF-9FBC-818D172CD1CEQ28548432-5C6D7D79-4114-468F-B6CB-A481F59ECB4CQ28550552-646C0F4B-AAD3-401F-93DD-7D2D87699F62Q31114921-660B9C19-7649-4862-A2F8-388C39BCF5D8Q33584656-BE30EF29-D4D2-4590-B7D5-51D8D2D6EC8FQ34612284-4DDF8F9C-A634-4594-A416-6C1C5D52DAD6Q34731031-C6DFC51C-4B2D-47C0-833F-6E8C4F4ACEF1Q34969496-F347E39C-F106-4B6E-A250-AB20E9EDD705Q35074204-66570BA5-6453-4AAF-AFE4-0CD426E71DD6Q35497470-B3D12757-BB30-439F-AA53-286D22B3AA45Q35765737-F5D6E2B3-F347-4934-A8B1-E79A1F6D8C55Q35917545-587FB2E0-D90C-493F-B053-DA498A3419FCQ35917568-AACE9450-5DCE-47B2-AD93-3133E4C7FF51Q36558909-CD6B940D-0D59-4CBC-BBB2-BFCF9191FEB8Q36581795-A296E510-1506-4E06-A19B-29A91B9DE632Q36959418-29AB1E7A-CB19-4D3E-865A-3738BD33D86BQ37269681-ED74C62B-F233-48DC-95A5-6FC8B1E74422Q37326870-C5834147-01E0-4582-BC44-F404E34B6768Q37517997-613678D7-146D-4976-879F-ADE536BF967FQ38789600-57E43DB4-2823-4FEB-ABCB-4085F094D9A0Q41746080-0A422022-9906-49E9-8468-FAB6B83155F6Q42217047-5D4BEDE6-9A4B-41D8-ACCF-F98DCBB6D64FQ42250345-FF9A7326-801C-4464-9C9D-2DA5139B5A35Q45367650-BF4CDACA-0A0F-479B-B3CE-CAD6CE0516B2Q46692659-67D3D8FC-A251-4F1A-8987-E7302E3FB845Q46858445-EC2574B3-AE6F-4FF0-8DCF-E4532602634F
P2860
Low Levels of Antiretroviral‐Resistant HIV Infection in a Routine Clinic in Cameroon that Uses the World Health Organization (WHO) Public Health Approach to Monitor Antiretroviral Treatment and Adequacy with the WHO Recommendation for Second‐Line
description
article
@en
im Mai 2009 veröffentlichter wissenschaftlicher Artikel
@de
wetenschappelijk artikel
@nl
наукова стаття, опублікована в травні 2009
@uk
name
Low Levels of Antiretroviral‐R ...... Recommendation for Second‐Line
@en
Low Levels of Antiretroviral‐R ...... the World Health Organization
@nl
type
label
Low Levels of Antiretroviral‐R ...... Recommendation for Second‐Line
@en
Low Levels of Antiretroviral‐R ...... the World Health Organization
@nl
prefLabel
Low Levels of Antiretroviral‐R ...... Recommendation for Second‐Line
@en
Low Levels of Antiretroviral‐R ...... the World Health Organization
@nl
P2093
P50
P356
P1476
Low Levels of Antiretroviral‐R ...... Recommendation for Second‐Line
@en
P2093
Anke Bourgeois
Avelin Aghokeng
Celine Montavon
Christian Laurent
Eitel Mpoudi‐Ngole
Sinata Koulla‐Shiro
P304
P356
10.1086/597779
P407
P577
2009-05-01T00:00:00Z